Olfa Derbel

1.5k citations
34 papers · 869 · 1 hit paper · h-index 13

Impact in

Papers in

    • PARP inhibition in cancer therapy 5
    • Cancer Immunotherapy and Biomarkers 2
    • Ovarian cancer diagnosis and treatment 5

Olfa Derbel

32 papers receiving 852 citations

Olfa Derbel's Hit Papers

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial 2022 · 255 citations
2550+1+2Years since publication50100150200250

Peers

Olfa Derbel
Comparison fields: 5 of 41
  • Cancer Research 178
  • Pulmonary and Respiratory Medicine 298
  • Rheumatology 92
  • Oncology 148
  • Endocrinology, Diabetes and Metabolism 85
Replace Geeta S. Mantha with:
Geeta S. Mantha United States
Marina Pulido France
Alain Zannetti France
Eriko Aimono Japan
Josefina Cruz Jurado Spain
Kirsten M. Leu United States
Olga L. Bohn United States
Tatianna Larman United States
Minetta C. Liu United States
Hana Vošmiková Czechia
Olfa Derbel relative to Geeta S. Mantha United States Geeta S. Mantha's profile →
Citations per field
00.5×5×10.6×
Geeta S. Mantha · 1×
Citations per year

Countries citing papers authored by Olfa Derbel

Since Specialization
Citations

This map shows the geographic impact of Olfa Derbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olfa Derbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olfa Derbel more than expected).

Fields of papers citing papers by Olfa Derbel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olfa Derbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olfa Derbel. The network helps show where Olfa Derbel may publish in the future.

Co-authors

The 25 scholars most cited alongside Olfa Derbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olfa Derbel Line = papers co-authored together Olfa Derbel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2022255
2 201173
3 201773
4 201366
5 201359
6 201751
7 201542
8 201231
9 201925
10 201323
11 202423
12 201222
13 201918
14 201913
15 202413
16 201211
17 201510
18 20138
19 20117
20 20136

About Olfa Derbel

Olfa Derbel is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology, having authored 34 papers that have together received 869 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (5 papers), BRCA gene mutations in cancer (4 papers), Bone Tumor Diagnosis and Treatments (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (178 citations), Pulmonary and Respiratory Medicine (298 citations), Rheumatology (92 citations), Oncology (148 citations) and Endocrinology, Diabetes and Metabolism (85 citations). Olfa Derbel has collaborated with scholars based in France, Spain and Switzerland. Frequent co-authors include Jean‐Yves Blay, Philippe Alexandre Cassier, Isabelle Laure Ray-Coquard, Anne‐Valérie Decouvelaere, Pierre Méeus, Christelle de la Fouchardière, Dominique Ranchère‐Vince, Gualter Vaz, Alice Bonneville-Levard and Olivier Collard. Their work appears in journals such as Annals of Oncology, BMC Cancer, Nature Communications, The Breast and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact